Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity.
| dc.contributor.author | Brantner, Carly Lupton | |
| dc.contributor.author | Chang, Ting-Hsuan | |
| dc.contributor.author | Nguyen, Trang Quynh | |
| dc.contributor.author | Hong, Hwanhee | |
| dc.contributor.author | Stefano, Leon Di | |
| dc.contributor.author | Stuart, Elizabeth A | |
| dc.date.accessioned | 2024-08-07T15:09:17Z | |
| dc.date.available | 2024-08-07T15:09:17Z | |
| dc.date.issued | 2023-11 | |
| dc.description.abstract | Estimating treatment effects conditional on observed covariates can improve the ability to tailor treatments to particular individuals. Doing so effectively requires dealing with potential confounding, and also enough data to adequately estimate effect moderation. A recent influx of work has looked into estimating treatment effect heterogeneity using data from multiple randomized controlled trials and/or observational datasets. With many new methods available for assessing treatment effect heterogeneity using multiple studies, it is important to understand which methods are best used in which setting, how the methods compare to one another, and what needs to be done to continue progress in this field. This paper reviews these methods broken down by data setting: aggregate-level data, federated learning, and individual participant-level data. We define the conditional average treatment effect and discuss differences between parametric and nonparametric estimators, and we list key assumptions, both those that are required within a single study and those that are necessary for data combination. After describing existing approaches, we compare and contrast them and reveal open areas for future research. This review demonstrates that there are many possible approaches for estimating treatment effect heterogeneity through the combination of datasets, but that there is substantial work to be done to compare these methods through case studies and simulations, extend them to different settings, and refine them to account for various challenges present in real data. | |
| dc.identifier.issn | 0883-4237 | |
| dc.identifier.issn | 2168-8745 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Institute of Mathematical Statistics | |
| dc.relation.ispartof | Statistical science : a review journal of the Institute of Mathematical Statistics | |
| dc.relation.isversionof | 10.1214/23-sts890 | |
| dc.rights.uri | ||
| dc.subject | Treatment effect heterogeneity | |
| dc.subject | combining data | |
| dc.subject | generalizability and reproducibility | |
| dc.title | Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Brantner, Carly Lupton|0000-0003-1067-3260 | |
| duke.contributor.orcid | Hong, Hwanhee|0000-0002-3736-6327 | |
| pubs.begin-page | 640 | |
| pubs.end-page | 654 | |
| pubs.issue | 4 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Biostatistics & Bioinformatics | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | Biostatistics & Bioinformatics, Division of Biostatistics | |
| pubs.publication-status | Published | |
| pubs.volume | 38 |
Files
Original bundle
- Name:
- Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity.pdf
- Size:
- 195.78 KB
- Format:
- Adobe Portable Document Format